EVpedia 2.0

This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:

Superdomain: All Prokaryote Eukaryote

Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).

Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.

Number of molecules in one page:

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name	miRBase accession	FPR	TPR	Publication	Orthologous group	Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5)
hsa-miR-4745-5p	MIMAT0019878	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4763-3p	MIMAT0019913	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	17 / 0 / 17
hsa-miR-4763-3p	MIMAT0019913	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	17 / 0 / 17
hsa-miR-4778-5p	MIMAT0019936	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-4778-5p	MIMAT0019936	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-4787-5p	MIMAT0019956	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4787-5p	MIMAT0019956	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4788	MIMAT0019958	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001573_1	21 / 0 / 21
hsa-miR-4788	MIMAT0019958	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001573_1	21 / 0 / 21
hsa-miR-4793-5p	MIMAT0019965	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4793-5p	MIMAT0019965	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4800-5p	MIMAT0019978	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-4800-5p	MIMAT0019978	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-483-5p	MIMAT0004761	0.0e+0	2.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000180_1	54 / 0 / 54
hsa-miR-483-5p	MIMAT0004761	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000180_1	54 / 0 / 54
hsa-miR-494-3p	MIMAT0002816	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-494-3p	MIMAT0002816	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-5001-5p	MIMAT0021021	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-5001-5p	MIMAT0021021	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-5006-5p	MIMAT0021033	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-5006-5p	MIMAT0021033	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-5100	MIMAT0022259	0.0e+0	1.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-5100	MIMAT0022259	0.0e+0	3.2e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-5195-3p	MIMAT0021127	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-5195-3p	MIMAT0021127	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-5703	MIMAT0022496	0.0e+0	9.5e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-5703	MIMAT0022496	0.0e+0	9.4e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-572	MIMAT0003237	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000537_1	27 / 0 / 27
hsa-miR-5739	MIMAT0023116	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	18 / 0 / 18
hsa-miR-5739	MIMAT0023116	0.0e+0	1.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	18 / 0 / 18
hsa-miR-575	MIMAT0003240	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000586_1	46 / 0 / 46
hsa-miR-575	MIMAT0003240	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000586_1	46 / 0 / 46
hsa-miR-5787	MIMAT0023252	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	28 / 0 / 28
hsa-miR-5787	MIMAT0023252	0.0e+0	1.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	28 / 0 / 28
hsa-miR-584-5p	MIMAT0003249	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000533_1	34 / 0 / 34
hsa-miR-584-5p	MIMAT0003249	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000533_1	34 / 0 / 34
hsa-miR-6068	MIMAT0023693	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-6068	MIMAT0023693	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-6076	MIMAT0023701	0.0e+0	1.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	17 / 0 / 17
hsa-miR-6076	MIMAT0023701	0.0e+0	1.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	17 / 0 / 17
hsa-miR-6085	MIMAT0023710	0.0e+0	2.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	26 / 0 / 26
hsa-miR-6085	MIMAT0023710	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	26 / 0 / 26
hsa-miR-6086	MIMAT0023711	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	15 / 0 / 15
hsa-miR-6087	MIMAT0023712	0.0e+0	7.6e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	16 / 0 / 16
hsa-miR-6087	MIMAT0023712	0.0e+0	4.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	16 / 0 / 16
hsa-miR-6088	MIMAT0023713	0.0e+0	1.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-6088	MIMAT0023713	0.0e+0	8.9e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-6089	MIMAT0023714	0.0e+0	5.3e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001510_1	16 / 0 / 16
hsa-miR-6089	MIMAT0023714	0.0e+0	3.9e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001510_1	16 / 0 / 16
hsa-miR-6090	MIMAT0023715	0.0e+0	7.3e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	28 / 0 / 28
hsa-miR-6090	MIMAT0023715	0.0e+0	6.4e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	28 / 0 / 28
hsa-miR-6124	MIMAT0024597	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-6124	MIMAT0024597	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-6124	MIMAT0024597	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-6125	MIMAT0024598	0.0e+0	9.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	28 / 0 / 28
hsa-miR-6125	MIMAT0024598	0.0e+0	1.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	28 / 0 / 28
hsa-miR-6126	MIMAT0024599	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-6127	MIMAT0024610	0.0e+0	2.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001405_1	10 / 0 / 10
hsa-miR-6127	MIMAT0024610	0.0e+0	2.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001405_1	10 / 0 / 10
hsa-miR-6165	MIMAT0024782	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	20 / 0 / 20
hsa-miR-6165	MIMAT0024782	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	20 / 0 / 20
hsa-miR-630	MIMAT0003299	0.0e+0	7.4e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000653_1	46 / 0 / 46
hsa-miR-630	MIMAT0003299	0.0e+0	7.1e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000653_1	46 / 0 / 46
hsa-miR-638	MIMAT0003308	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000486_1	85 / 0 / 85
hsa-miR-638	MIMAT0003308	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000486_1	85 / 0 / 85
hsa-miR-642a-3p	MIMAT0020924	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000468_2	28 / 0 / 28
hsa-miR-642a-3p	MIMAT0020924	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000468_2	28 / 0 / 28
hsa-miR-642a-3p	MIMAT0020924	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000468_2	28 / 0 / 28
hsa-miR-642b-3p	MIMAT0018444	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000468_2	28 / 0 / 28
hsa-miR-642b-3p	MIMAT0018444	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000468_2	28 / 0 / 28
hsa-miR-6510-5p	MIMAT0025476	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-6510-5p	MIMAT0025476	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-6511b-5p	MIMAT0025847	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001382_1	4 / 0 / 4
hsa-miR-6511b-5p	MIMAT0025847	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001382_1	4 / 0 / 4
hsa-miR-6515-5p	MIMAT0025486	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	1 / 0 / 1
hsa-miR-671-5p	MIMAT0003880	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000358_1	66 / 0 / 66
hsa-miR-671-5p	MIMAT0003880	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000358_1	66 / 0 / 66
hsa-miR-6720-3p	MIMAT0025851	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	7 / 0 / 7
hsa-miR-6722-3p	MIMAT0025854	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	7 / 0 / 7
hsa-miR-6724-5p	MIMAT0025856	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001920_1	12 / 0 / 12
hsa-miR-6724-5p	MIMAT0025856	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001920_1	12 / 0 / 12
hsa-miR-762	MIMAT0010313	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000624_1	60 / 0 / 60
hsa-miR-762	MIMAT0010313	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000624_1	60 / 0 / 60
hsa-miR-765	MIMAT0003945	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000545_1	47 / 0 / 47
hsa-miR-877-5p	MIMAT0004949	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000392_1	42 / 0 / 42
hsa-miR-877-5p	MIMAT0004949	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000392_1	42 / 0 / 42
hsa-miR-877-5p	MIMAT0004949	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000392_1	42 / 0 / 42
hsa-miR-877-5p	MIMAT0004949	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000392_1	42 / 0 / 42
hsa-miR-9-3p	MIMAT0000442	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000014_2	25 / 0 / 25
hsa-miR-9-3p	MIMAT0000442	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000014_2	25 / 0 / 25
hsa-miR-92a-3p	MIMAT0000092	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000013_2	73 / 0 / 73
hsa-miR-92a-3p	MIMAT0000092	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000013_2	73 / 0 / 73
hsa-miR-93-5p	MIMAT0000093	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000001_1	99 / 0 / 99
hsa-miR-937-5p	MIMAT0022938	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000560_1	15 / 0 / 15
hsa-miR-937-5p	MIMAT0022938	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000560_1	15 / 0 / 15
hsa-miR-939-5p	MIMAT0004982	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000490_1	60 / 0 / 60
#N/A	MIMAT0022734	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
#N/A	MIMAT0022734	0.0e+0	9.2e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
#N/A	MIMAT0022944	0.0e+0	9.0e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
#N/A	MIMAT0022944	0.0e+0	8.4e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8

< [572] [573] [574] [575] [576] [577] [578] [579] [580] [581] >